Precision BioSciences (NASDAQ:DTIL) Friday announced that its Board of Directors has approved a 1-for-30 reverse stock split of the company’s common stock to increase the per-share market price to meet the minimum per share bid price requirement for continued listing on The Nasdaq Capital Market. The reverse stock split will become effective at 5:00 p.m. Eastern Time on February 13, 2024, after close of trading on The Nasdaq Capital Market. The company’s common stock is expected to commence trading on a split-adjusted basis when the markets open on February 14, 2024 under the existing trading symbol “DTIL.” DTIL -3.70% premarket to $0.385 Source: Press Release
Subscribe to Updates
Get the latest markets and assets news and updates directly to your inbox.
Keep Reading
© 2025 The Asset Observer. All Rights Reserved.